Article

Seattle TimesSeattle Times on 2019-04-30 13:23

Merck shares soar along with its first quarter profit

Surging sales of vaccines and the cancer immunotherapy drug Keytruda led to a quadrupling of profit at Merck during the first quarter as it blew past ...

Related news